Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from a ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Turbuhaler contains two active ingredients in one inhaler: ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Oxis Turbuhaler? Oxis Turbuhaler contains the active ...

Clin Drug Invest. 2005;25(8):543-549. As shown in table II, slightly more than 80% of patients claimed that they had received some instruction on inhalation technique at the time of first prescription ...

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced the approval of the company's Symbicort Turbuhaler in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve ...

AstraZeneca has unveiled data from two Phase III trials showing the benefit of using Symbicort Turbuhaler as an anti-inflammatory reliever ‘as needed’ versus two different treatment regimens in ...

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response ...

The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol. AstraZeneca’s Novel START trial for its Symbicort Turbuhaler ...

(Alliance News) - AstraZeneca PLC on Tuesday said its Symbicort Turbuhaler has been approved in China to treat mild asthma, becoming the first dual-combination therapy approved in the country for mild ...